147 related articles for article (PubMed ID: 34063766)
1. Strategies for the Production of Soluble Interferon-Alpha
Grabarz F; Lopes APY; Barbosa FF; Barazzone GC; Santos JC; Botosso VF; Jorge SAC; Nascimento ALTO; Astray RM; Gonçalves VM
Life (Basel); 2021 May; 11(6):. PubMed ID: 34063766
[TBL] [Abstract][Full Text] [Related]
2. Auto-induction expression of human consensus interferon-alpha in Escherichia coli.
EL-Baky NA; Linjawi MH; Redwan EM
BMC Biotechnol; 2015 Mar; 15():14. PubMed ID: 25886839
[TBL] [Abstract][Full Text] [Related]
3. Optimization of conditions for high-level expression and purification of human recombinant consensus interferon (rh-cIFN) and its characterization.
Ahmed N; Bashir H; Zafar AU; Khan MA; Tahir S; Khan F; Khan MI; Akram M; Husnain T
Biotechnol Appl Biochem; 2015; 62(5):699-708. PubMed ID: 25402716
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and characterization of recombinant human consensus interferon-alpha in Escherichia coli under λP(L) promoter.
Mohammed Y; El-Baky NA; Redwan EM
Prep Biochem Biotechnol; 2012; 42(5):426-47. PubMed ID: 22897766
[TBL] [Abstract][Full Text] [Related]
5. Consensus interferon: a novel interferon for the treatment of hepatitis C.
Heathcote J
J Viral Hepat; 1998 Sep; 5 Suppl 1():13-8. PubMed ID: 9795924
[TBL] [Abstract][Full Text] [Related]
6. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
[TBL] [Abstract][Full Text] [Related]
8. Production of potent long-lasting consensus interferon using albumin fusion technology in Pichia pastoris expression system.
Naseem MU; Ahmed N; Khan MA; Tahir S; Zafar AU
Protein Expr Purif; 2020 Feb; 166():105509. PubMed ID: 31604114
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C.
Ding YH; Liu B; Zhang X; Sun L; Zhang H; Luo H; Sun YF; Liu CJ; Zhang Q; Cao YC; Chen H; Niu JQ
Exp Ther Med; 2017 Jan; 13(1):9-16. PubMed ID: 28123460
[TBL] [Abstract][Full Text] [Related]
10. The anti-cancer activity of human consensus interferon-alpha synthesized in cell-free system.
El-Baky NA; Omar SH; Redwan EM
Protein Expr Purif; 2011 Nov; 80(1):61-7. PubMed ID: 21802515
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfacon-1: a novel interferon for the treatment of chronic hepatitis C.
Alberti A
BioDrugs; 1999 Nov; 12(5):343-57. PubMed ID: 18031187
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys.
Du Y; Tian H; Gao XD; Yao WB
Biopharm Drug Dispos; 2008 Nov; 29(8):481-4. PubMed ID: 18985796
[TBL] [Abstract][Full Text] [Related]
14. Expression of canine interferon-gamma by a recombinant vaccinia virus and its antiviral effect.
Nishikawa Y; Iwata A; Katsumata A; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
Virus Res; 2001 Jun; 75(2):113-21. PubMed ID: 11325466
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
Jensen DM; Krawitt EL; Keeffe EB; Hollinger FB; James SP; Mullen K; Everson GT; Hoefs JC; Fromm H; Black M; Foust RT; Pimstone NR; Heathcote EJ; Albert D
Am J Gastroenterol; 1999 Dec; 94(12):3583-8. PubMed ID: 10606323
[TBL] [Abstract][Full Text] [Related]
16. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
[TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of the canine interferon-gamma gene.
Devos K; Duerinck F; Van Audenhove K; Fiers W
J Interferon Res; 1992 Apr; 12(2):95-102. PubMed ID: 1578190
[TBL] [Abstract][Full Text] [Related]
18. Incomplete protein disulphide bond conformation and decreased protein expression result from high cell growth during heterologous protein expression in Pichia pastoris.
Wu D; Chu J; Hao YY; Wang YH; Zhuang YP; Zhang SL
J Biotechnol; 2012 Jan; 157(1):107-12. PubMed ID: 21924302
[TBL] [Abstract][Full Text] [Related]
19. [Adenovirus-mediated canine interferon-gamma expression and its antiviral activity against canine parvovirus].
Zhang K; Jin H; Zhong F; Li X; Neng C; Chen H; Li W; Wen J
Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1400-7. PubMed ID: 23383512
[TBL] [Abstract][Full Text] [Related]
20. An open-label trial of consensus interferon 15 µg in the treatment of Chinese patients with chronic hepatitis C.
Hwang S; Lee S; Chu C; Lu R; Chang F
Hepatol Res; 2001 Mar; 19(3):284-293. PubMed ID: 11251311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
